News & Filings
ORCHPHARMA \u2014 Recent Activity
8 items in the last 14 days
7 Tokens Face Binance Delisting Threat as Exchange Expands Watchlist
Binance added 7 tokens to its Monitoring Tag list on April 14. All posted sharp losses as traders weigh delisting risk.
Click to open →
Orchid Pharma Ltd (BOM:524372) Q3 2026 Earnings Call Highlights: Navigating Challenges with ...
Despite a decline in sales and EBITDA margins, Orchid Pharma Ltd (BOM:524372) focuses on growth through increased R&D and new market launches.
Click to open →
Compass Point Initiates Coverage on Orchid Island Capital (ORC) at Neutral
Orchid Island Capital, Inc. (NYSE:ORC) is included among the 13 Highest Paying Monthly Dividend Stocks to Buy. On December 15, Compass Point started coverage of Orchid Island Capital, Inc. (NYSE:ORC) with a Neutral rating and a $7.50 price target. In its Q3 2025 earnings, the company said market conditions were supportive for levered Agency RMBS […]
Click to open →
Orchid Pharma Ltd (BOM:524372) Q2 2026 Earnings Call Highlights: Strategic Acquisitions and ...
Orchid Pharma Ltd (BOM:524372) reports a 13% sequential sales increase and strategic acquisitions, despite facing year-on-year sales decline and margin pressures.
Click to open →
Orchid vs. Starwood: Which Mortgage REIT Has Better Upside?
Does ORC's zero debt, rising earnings and 20.4% dividend yield set it apart from STWD's debt-heavy, slower-growth profile? Let us find out.
Click to open →
Orchid Projects Loss for Q2: Is RMBS Strategy Backfiring?
ORC projects a second-quarter loss as RMBS and derivative losses weigh on book value and expose interest rate risk.
Click to open →
Orchid Offers 20.1% Dividend Yield: A Powerful Income Play?
Does ORC's massive 20.1% dividend yield, debt-free balance sheet and solid liquidity make it a standout for income-focused investors?
Click to open →
Is Orchid Stock Worth Buying for Its Lucrative 20.3% Dividend Yield?
ORC offers a staggering 20.3% dividend yield, but is its lofty valuation a red flag for cautious investors? Read on to find out.
Click to open →
Get alerts for important filings
Add ORCHPHARMA to your watchlist for board meeting & dividend alerts.
Open analysis →News from yfinance + BSE corporate announcements. Importance scoring is automated. YieldIQ is not registered with SEBI as an investment adviser.